Login / Signup

Retrograde autologous priming to reduce allogeneic blood transfusion requirements: a systematic review.

Nousjka Pa VrankenZaheer Ud BabarJesse A MontoyaPatrick W Weerwind
Published in: Perfusion (2020)
Although most studies reported significantly fewer packed red blood cell transfusions in the retrograde autologous priming group, it is important to note that relatively few articles are available which are flawed by several types of bias. Prospective, randomized multi-center trials are warranted to conclude decisively on the benefits of retrograde autologous priming.
Keyphrases
  • bone marrow
  • red blood cell
  • cell therapy
  • platelet rich plasma
  • stem cell transplantation
  • open label
  • double blind
  • stem cells
  • placebo controlled
  • clinical trial
  • phase iii
  • case control
  • hematopoietic stem cell